Funder
AstraZeneca KK
Kanagawa Prefectural Hospital Organization
Reference33 articles.
1. Lung cancer;Hoffman;Lancet,2000
2. Lung cancer;Herbst;N. Engl. J. Med.,2008
3. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl. J. Med.,2010
4. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol.,2010
5. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol.,2011